Ilse Treurnicht is the CEO of the MaRS Discovery District. She joined MaRS from her role as President & CEO of Primaxis Technology Ventures, a start-up stage venture capital fund focused on the advanced technologies sector. Prior to Primaxis, Ilse was an entrepreneur with senior management roles in a number of emerging technology companies. She serves on a number of Boards, including the Canadian Institute for Advanced Research (CIFAR), BIOTECanada and Aggregate Therapeutics. Ilse holds a DPhil in chemistry from Oxford University, which she attended as a Rhodes Scholar.
Dr. Ilse Treurnicht’s biography is available for download and printing: | |
